The HAS‐BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis
- 29 September 2015
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 38 (9) , 555-561
Abstract
Our objective was to compare the diagnostic accuracy between the HAS‐BLED score and any of HEMORR2HAGES, ATRIA, CHADS2, or CHA2DS2‐VASc scores in anticoagulated patients with atrial fibrillation. We systematically searched the Cochrane Library, MEDLINE, PubMed, and Embase databases for relevant studies. Data were extracted and analyzed according to predefined clinical endpoints. Eleven studies were identified. Discrimination analysis demonstrates that HAS‐BLED has no significant C‐statistic differences for bleeding risk prediction compared with ATRIA or HEMORR2HAGES, but it has significant differences compared with CHADS2 or CHA2DS2‐VASc. The significant positive net reclassification improvement and integrated discrimination improvement values also show that HAS‐BLED is superior to that of any of HEMORR2HAGES, ATRIA, CHADS2, or CHA2DS2‐VASc scores. According to calibration analysis of HAS‐BLED, it overpredicts the risk of bleeding in the low (risk ratio [RR]: 1.16, 95% confidence interval [CI]: 0.63‐2.13, P = 0.64) risk stratification but underpredicts that in the moderate (RR: 0.66, 95% CI: 0.51‐0.86, P = 0.002) and high (RR: 0.88, 95% CI: 0.70‐1.10, P = 0.27) risk stratifications. The HAS‐BLED score not only performs better than the HEMORR2HAGES and ATRIA bleeding scores, but it also is superior to the CHADS2 and CHA2DS2‐VASc stroke scores for bleeding prediction. The HAS‐BLED score should be the optimal choice to assess major bleeding risk in clinical practice.Keywords
This publication has 29 references indexed in Scilit:
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillationEP Europace, 2012
- Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2012
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort studyEuropean Heart Journal, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- A New Risk Scheme to Predict Warfarin-Associated HemorrhageJACC, 2011
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial FibrillationJACC, 2011
- Executive Summary: Heart Disease and Stroke Statistics—2010 UpdateCirculation, 2010
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial FibrillationEuropean Heart Journal, 2006
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006